Study Stopped
study abandoned
Circumferential Submucosal Incision Endoscopic Mucosal Resection Versus Conventional Endoscopic Mucosal Resection of Colonic Polyps
CSIEMR
1 other identifier
interventional
N/A
1 country
1
Brief Summary
That Circumferential Submucosal Incision Endoscopic Mucosal Resection (CSI-EMR) will be at least as safe but more effective than conventional EMR for injection assisted EMR of large laterally spreading tumour and sessile polyps of the colon.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
Started Mar 2020
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
June 6, 2011
CompletedFirst Posted
Study publicly available on registry
June 8, 2011
CompletedStudy Start
First participant enrolled
March 9, 2020
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 9, 2020
CompletedStudy Completion
Last participant's last visit for all outcomes
March 9, 2020
CompletedMarch 27, 2025
March 1, 2025
Same day
June 6, 2011
March 25, 2025
Conditions
Outcome Measures
Primary Outcomes (1)
Efficacy of CSI EMR (Rates of en-bloc resection, recurrence rates)
3 months
Study Arms (2)
Circumferential Submucosal Incision Resection
EXPERIMENTALEndoscopic Mucosal Resection
ACTIVE COMPARATORPatients randomised into this arm will receive the conventional treatment Endoscopic Mucosal Resection in which the sessile lesion is injected and snared by piecemeal technique.
Interventions
The patient is randomized, if in the active arm the procedure will continue as Circumferential Submucosal Incision Endoscopic Mucosal Resection.
Patients randomised into this Intervention type will have Endoscopic Mucosal Resection performed
Eligibility Criteria
You may qualify if:
- Can give informed consent to trial participation
- Age greater than 18
- Adenomas that have not have previously been attempted for resection (i.e. naïve lesions)
- Adenoma size greater than 20 mm
You may not qualify if:
- Age less than 18
- Previous resection or attempted resection of target adenoma lesion
- Pregnant patients
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Westmead Hospital
Westmead, New South Wales, 2145, Australia
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Michael J Bourke
Westmead Hospital - Endoscopy Unit
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- INVESTIGATOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR INVESTIGATOR
- PI Title
- Dr Michael Bourke
Study Record Dates
First Submitted
June 6, 2011
First Posted
June 8, 2011
Study Start
March 9, 2020
Primary Completion
March 9, 2020
Study Completion
March 9, 2020
Last Updated
March 27, 2025
Record last verified: 2025-03